MedTrace Logo

Healthy Human Control Blood Collection for Validation of Biomarker Assay

NCT02302885 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2026-01-29

No results posted yet for this study

Summary

Human blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population is cancer-free 18-60 year old men and women. Volunteer selection will rely upon a short health questionnaire. About 20 mL blood will be collected from volunteers up to 20 different timepoints. The Procedure involves minimal risk of harm (eg discomfort, bruising) to the volunteer.

Conditions

  • Healthy

Interventions

OTHER

Blood collection

Blood Collection

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Jay Dorsey, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-12-31
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302885 on ClinicalTrials.gov